Samcro Hyosung Adilestari Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Samcro Hyosung Adilestari Tbk. trades at Rp63 (market cap 218.57B, 5.19M 24h volume), while Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume). The key difference: Samcro Hyosung Adilestari Tbk. is the larger of the two by market cap, and Cipta Sarana Medika Tbk. is more actively traded (14.05M versus 5.19M). Which is the better fit depends on your goals.
| ACRO | DKHH | |
|---|---|---|
Market Cap | 218.57B | 160.67B |
Volume | 5.19M | 14.05M |
Lot | 51.94K | 140.49K |
Turnover | 327.46M | 899.67M |
Average Price | 63.04 | 64.04 |
Value | 327.46M | 899.67M |
Indicative Equilibrium Price | 63 | 64 |
Indicative Equilibrium Volume | 957 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Samcro Hyosung Adilestari Tbk (The Company) was established on Republic of Indonesia based on Deed of Establishment No. 265 dated July 21, 1989 by Yudo Paripurno, S.H., Notary in Jakarta.
Read more on ACRO →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →